Literature DB >> 22782974

Promoter methylation confers kidney-specific expression of the Klotho gene.

Masahiro Azuma1, Daisuke Koyama, Jiro Kikuchi, Hiromichi Yoshizawa, Dissayabutra Thasinas, Kazuhiro Shiizaki, Makoto Kuro-o, Yusuke Furukawa, Eiji Kusano.   

Abstract

The aging suppressor geneKlotho is predominantly expressed in the kidney irrespective of species. Because Klotho protein is an essential component of an endocrine axis that regulates renal phosphate handling, the kidney-specific expression is biologically relevant; however, little is known about its underlying mechanisms. Here we provide in vitro and in vivo evidence indicating that promoter methylation restricts the expression of the Klotho gene in the kidney. Based on evolutionary conservation and histone methylation patterns, the region up to -1200 bp was defined as a major promoter element of the human Klotho gene. This region displayed promoter activity equally in Klotho-expressing and -nonexpressing cells in transient reporter assays, but the activity was reduced to ∼20% when the constructs were integrated into the chromatin in the latter. Both endogenous and transfected Klotho promoters were 30-40% methylated in Klotho-nonexpressing cells, but unmethylated in Klotho-expressing renal tubular cells. DNA demethylating agents increased Klotho expression 1.5- to 3.0-fold in nonexpressing cells and restored the activity of silenced reporter constructs. Finally, we demonstrated that a severe hypomorphic allele of Klotho had aberrant CpG methylation in kl/kl mice. These findings might be useful in therapeutic intervention for accelerated aging and several complications caused by Klotho down-regulation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22782974      PMCID: PMC3448772          DOI: 10.1096/fj.12-211631

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  60 in total

1.  Klotho is silenced through promoter hypermethylation in gastric cancer.

Authors:  Liangjing Wang; Xian Wang; Xiaojia Wang; Pan Jie; Haiqi Lu; Shengjie Zhang; Xiaoying Lin; Emily Ky Lam; Yan Cui; Jun Yu; Hongchuan Jin
Journal:  Am J Cancer Res       Date:  2010-11-10       Impact factor: 6.166

2.  Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule.

Authors:  Ming Chang Hu; Mingjun Shi; Jianning Zhang; Johanne Pastor; Teruyo Nakatani; Beate Lanske; M Shawkat Razzaque; Kevin P Rosenblatt; Michel G Baum; Makoto Kuro-o; Orson W Moe
Journal:  FASEB J       Date:  2010-05-13       Impact factor: 5.191

3.  DNA modification mechanisms and gene activity during development.

Authors:  R Holliday; J E Pugh
Journal:  Science       Date:  1975-01-24       Impact factor: 47.728

4.  Establishment of the anti-Klotho monoclonal antibodies and detection of Klotho protein in kidneys.

Authors:  Y Kato; E Arakawa; S Kinoshita; A Shirai; A Furuya; K Yamano; K Nakamura; A Iida; H Anazawa; N Koh; A Iwano; A Imura; T Fujimori; M Kuro-o; N Hanai; K Takeshige; Y Nabeshima
Journal:  Biochem Biophys Res Commun       Date:  2000-01-19       Impact factor: 3.575

Review 5.  Role of Klotho in aging, phosphate metabolism, and CKD.

Authors:  George B John; Chung-Yi Cheng; Makoto Kuro-o
Journal:  Am J Kidney Dis       Date:  2011-04-15       Impact factor: 8.860

6.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.

Authors:  Nathaniel D Heintzman; Rhona K Stuart; Gary Hon; Yutao Fu; Christina W Ching; R David Hawkins; Leah O Barrera; Sara Van Calcar; Chunxu Qu; Keith A Ching; Wei Wang; Zhiping Weng; Roland D Green; Gregory E Crawford; Bing Ren
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

7.  Severely reduced production of klotho in human chronic renal failure kidney.

Authors:  N Koh; T Fujimori; S Nishiguchi; A Tamori; S Shiomi; T Nakatani; K Sugimura; T Kishimoto; S Kinoshita; T Kuroki; Y Nabeshima
Journal:  Biochem Biophys Res Commun       Date:  2001-02-02       Impact factor: 3.575

8.  PGC7/Stella protects against DNA demethylation in early embryogenesis.

Authors:  Toshinobu Nakamura; Yoshikazu Arai; Hiroki Umehara; Masaaki Masuhara; Tohru Kimura; Hisaaki Taniguchi; Toshihiro Sekimoto; Masahito Ikawa; Yoshihiro Yoneda; Masaru Okabe; Satoshi Tanaka; Kunio Shiota; Toru Nakano
Journal:  Nat Cell Biol       Date:  2006-12-03       Impact factor: 28.824

9.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing.

Authors:  M Kuro-o; Y Matsumura; H Aizawa; H Kawaguchi; T Suga; T Utsugi; Y Ohyama; M Kurabayashi; T Kaname; E Kume; H Iwasaki; A Iida; T Shiraki-Iida; S Nishikawa; R Nagai; Y I Nabeshima
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

10.  Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation.

Authors:  Chiao-Yin Sun; Shih-Chung Chang; Mai-Szu Wu
Journal:  Kidney Int       Date:  2012-01-11       Impact factor: 10.612

View more
  38 in total

1.  MicroRNA-339 and microRNA-556 regulate Klotho expression in vitro.

Authors:  Stephen J Mehi; Astha Maltare; Carmela R Abraham; Gwendalyn D King
Journal:  Age (Dordr)       Date:  2013-07-02

2.  Expression of klotho mRNA and protein in rat brain parenchyma from early postnatal development into adulthood.

Authors:  Sarah M Clinton; Matthew E Glover; Astha Maltare; Ann M Laszczyk; Stephen J Mehi; Rebecca K Simmons; Gwendalyn D King
Journal:  Brain Res       Date:  2013-07-06       Impact factor: 3.252

Review 3.  Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism.

Authors:  Makoto Kuro-o
Journal:  Nat Rev Nephrol       Date:  2013-06-18       Impact factor: 28.314

Review 4.  Epigenetics of progression of chronic kidney disease: fact or fantasy?

Authors:  Maria R Wing; Ali Ramezani; Harindarpal S Gill; Joseph M Devaney; Dominic S Raj
Journal:  Semin Nephrol       Date:  2013-07       Impact factor: 5.299

Review 5.  The FGF23 and Klotho system beyond mineral metabolism.

Authors:  Makoto Kuro-O
Journal:  Clin Exp Nephrol       Date:  2016-11-12       Impact factor: 2.801

6.  Human alternative Klotho mRNA is a nonsense-mediated mRNA decay target inefficiently spliced in renal disease.

Authors:  Rik Mencke; Geert Harms; Jill Moser; Matijs van Meurs; Arjan Diepstra; Henri G Leuvenink; Jan-Luuk Hillebrands
Journal:  JCI Insight       Date:  2017-10-19

7.  Alpha-Klotho Enrichment in Induced Pluripotent Stem Cell Secretome Contributes to Antioxidative Protection in Acute Lung Injury.

Authors:  Amiq Gazdhar; Priya Ravikumar; Johanne Pastor; Manfred Heller; Jianfeng Ye; Jianning Zhang; Orson W Moe; Thomas Geiser; Connie C W Hsia
Journal:  Stem Cells       Date:  2017-12-25       Impact factor: 6.277

Review 8.  αKlotho-FGF23 interactions and their role in kidney disease: a molecular insight.

Authors:  Edward R Smith; Stephen G Holt; Tim D Hewitson
Journal:  Cell Mol Life Sci       Date:  2019-07-26       Impact factor: 9.261

9.  Klotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Michelle Wehling-Henricks; Zhenzhi Li; Catherine Lindsey; Ying Wang; Steven S Welc; Julian N Ramos; Négar Khanlou; Makoto Kuro-O; James G Tidball
Journal:  Hum Mol Genet       Date:  2016-05-06       Impact factor: 6.150

Review 10.  αKlotho and Chronic Kidney Disease.

Authors:  J A Neyra; M C Hu
Journal:  Vitam Horm       Date:  2016-03-24       Impact factor: 3.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.